USFDA approves Prasugrel tablets by Lupin
The product will be manufactured at Lupin’s facility in Goa
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
USFDA approves Febuxostat tablets by Zydus
The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad
Glenmark Pharma launches Bumetanide injection vials
According to IQVIA sales data for the 12-month period ending November 2022, the Bumex injection, 0.25 mg/mL market achieved annual…
Lupin and Exeltis announce reimbursement approval of NaMuscla
Agreement enables sustainable patient access of the only EU-approved treatment for myotonia symptoms
There is a high-quality talent pool in the specialist area of pharma engineering design in India
With over 55 per cent of the Dublin-based PM Group's business coming from the pharma sector, Anandhi Sathyamurthy, MD-India, PM…
Inflation, drug pricing and reimbursement constraints will have the biggest negative impact on…
The survey as part of GlobalData's ‘State of the Biopharmaceutical Industry 2023’ report, found that close to 40 per cent of…
Digital, Data and Dialogue: The 3D approach to enhance clinical trials in 2023
Deepak Gandotra, Senior Director, Enterprise Clinical Solutions, Indegene, believes the new year will see a stronger coupling…
Pfizer announces 12-week paternity leave policy for its employees
The policy will be applicable for biological and adoptive fathers from 1st January, 2023, onwards
Pricing pressures and regulatory overhang affect margins of Indian pharma companies in FY2023: ICRA
Outlook for the Indian pharma industry remains stable, led by expectations of continued steady revenue growth and comfortable…
USFDA grants priority review to Roche’s glofitamab
If approved, glofitamab would be the first fixed-duration CD20xCD3 T-cell engaging bi-specific antibody approved to treat the most…